Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Panama to get diagnostics boost in US pandemic preparedness MOU:

This article was originally published in Clinica

Executive Summary

The Panamanian government, Panama's Gorgas Memorial Institute (GMI) and the US Health and Human Services (HHS) department are to extend co-operation in the areas of pandemic preparedness and wider healthcare development. A memorandum of understanding signed by Panama's health minister, Dr Jorge Motta, GMI director general Dr Camilo Allenye and HHS secretary Mike Leavitt on April 14 focuses on improving surveillance, such as by increasing the capacity of the laboratory testing services, and speeding up the response, including the diagnosis, epidemiological investigation and control of disease. The GMI specialises in research in the fields of tropical medicine and health management. US interest in the agreement is based on the fact that Panama is seen as a gateway to human and bird migration from South America and therefore potentially instrumental in helping to monitor and contain an influenza pandemic.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT051423

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel